Afidopyropen Patent Landscape Analysis

Jointly discovered by the Kitasato Institute and Meiji Seika Pharma from naturally derived pyripyropene chemistry, afidopyropen was subsequently developed by BASF under the Inscalis® brand. Its distinct mode of action and strong activity against aphids, whiteflies, scale insects and populations resistant to established insecticides make it an important addition to sucking-pest and resistance-management programmes. BASF Inscalis

The updated report retains 177 patent families across 91 consolidated owner groups. The Meiji originator estate accounts for 44 families and is the only portfolio represented across all seven substantive protection layers. Nevertheless, extensive third-party activity—particularly from Chinese formulators—shows that the molecule has developed into a broad commercial platform.

Pesticide combinations dominate with 129 families across 75 holder groups. Twenty-three partner active ingredients are specifically named, while a further 101 families claim combinations without identifying a partner. The upstream estate contains ten compound, one crystal-form and 12 process and manufacturing families, together with 16 formulation families. A total of 128 families have a granted-active or national-pending reading, and 19 live families reach their nominal term within five years.

This 68-page report includes complete patent tables and a directory covering all 91 owner groups.

Not a freedom-to-operate opinion.